Increased melanogenesis in cultured epidermal melanocytes from patients with neurofibromatosis 1 (NF1)
β Scribed by Dieter Kaufmann; Suzanne Wiandt; Joseph Veser; Winfrid Krone
- Book ID
- 104662659
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 683 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
β¦ Synopsis
Melanocyte cultures from the normally pigmented skin of patients with neurofibromatosis 1 (NF 1) have a higher melanin content than those from the skin of healthy donors. An additional increase in the amount of melanin per cell was found in 5 out of 6 lines of melanocytes derived from caf6 au lait macules of NF 1 patients. Omission of the tumor promoter phorbol-12myristate-13-acetate from the culture medium brings about a comparable increase in the melanin content in all three kinds of melanocyte cultures. Cultures of NF 1 melanocytes show a higher tyrosine hydroxylase activity than those of control melanocytes, and incorporate larger amounts of dihydroxyphenylalanine than the latter. We conclude that melanogenesis in epidermis melanocytes is affected by defective alleles of the NF 1 gene. Our findings do not contradict the hypothesis that the defect underlying NF 1 impairs the inhibition of a wild-type RAS oncogene by interfering with the GTPaseactivating function of the NF 1 gene product.
π SIMILAR VOLUMES
Neurofibromatosis type 1 (NF1) is characterized by clinical features that primarily affect tissues derived from the neural crest (neurofibromas, caf~-aulait macules). Because aberrant regulation of alternative splicing in the NF1 gene transcript may be of functional significance, cultured melanocyte
Neurofibromatosis 1 (NF1) is an autosomal dominant disorder caused by genetic alterations of the NF1 gene on 17q11.2. About 30% of NF1 patients develop plexiform neurofibromas (PNFs), which often cause severe clinical deficits. To determine whether there is a certain genotype underlying PNFs or subt
4 from patients with Von Hippel-Lindau syndrome (m). The diagnosis was confirmed in each NF1 patient and conformed to internationally agreed criteria (Riccardi and Eichner, 1986;Mulvihill and Parry, 1987). The diagnosis of MEN 2 and VHL was similarly con-
We report a 21-year-old male with symptomatic optic glioma who does not fulfill the diagnosis of neurofibromatosis 1 (NF1) according to standard NIH criteria. Analysis of the NF1 gene revealed a recurrent mutation in exon 37 (C6792A or Y2264X). This nonsense mutation causes skipping of exon 37 durin